300401.SZ
Zhejiang Garden Biopharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 14.14
−8.42%Aug 14, 2026, 08:49 UTC
Garden Bio disclosed its semi-annual report on August 14, reporting first-half net profit attributable to shareholders of 132 million yuan, down 18.34% year-on-year.
Aug 13, 2026, 07:51 UTC
Garden Bio received a Drug Manufacturing License from Zhejiang Province Medical Products Administration, valid until August 9, 2031, marking its first such license and passing GMP compliance inspection.
Source: